BioCentury This Week

BioCentury This Week

Por: BioCentury
BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs.For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.
352 episodios disponibles

Latest episodes of the podcast BioCentury This Week

Mostrando página 9 de 18

Ep. 185 - Leqembi's Launch, Biotech IPOs, Sarepta Approval 10/07/2023
Ep. 184 - Califf's FDA reforms & Polaris' Schulman 26/06/2023
Ep. 183 - EMA's Cooke, What's Next for IPSCs, & Leerink is Back 19/06/2023
Ep. 182 - Merck’s IRA suit, Leqembi and MCEDs at ASCO 12/06/2023
Ep. 181 - Highlights from ASCO 05/06/2023
Ep. 180 - ASCO, Neuropsych & the IRA 30/05/2023
Ep. 179 - DMD Gene Therapies, CBER & NIH 22/05/2023
Ep. 178 - Live from Bio€quity, Part 2 16/05/2023
Ep. 177 - Live from Bio€quity, Part 1 15/05/2023
Ep. 176 - Bio€quity Europe 2023 Preview: Crafting a European Playbook for Success 09/05/2023
Ep. 175 - Acelyrin IPO, Alzheimer's Data & Digital Endpoints 08/05/2023
Ep. 174 - EC Pharma Law, ALS Biomarker, Astellas' Iveric Deal 01/05/2023
Ep. 173 - EU VC Funds, Abortion Drug Ruling, IRA Insights 24/04/2023
Ep. 172 - AACR Insights 20/04/2023
Ep. 171 - 2Q Markets Preview, Abortion Drug Rulings, Gilead Oncology 17/04/2023
Ep. 170 - Abortion Ruling & FDA; New VC Funds; IRA 10/04/2023
Ep. 169 - FTC & Illumina, Plus: PCSK9s at SCOTUS 03/04/2023
Ep. 168 - VCs' Take on SVB & New ALS Endpoint 27/03/2023
Ep. 167 - The IRA, T Cell Therapies & The Distillery 20/03/2023
Ep. 166 - SVB Shakeout: Next Steps for Biotech 17/03/2023
« Primera ‹ Anterior 1 ... 7 8 9 10 11 ... 18 Siguiente › Última »
© 2003-2026 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA